|
Volumn 37, Issue 2, 1998, Pages 217-218
|
1) Therapeutic efficacy of vasopressin receptor antagonist
a a |
Author keywords
Arginine vasopressin (AVP) antagonists; Hyponatremia; Water retention
|
Indexed keywords
1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE;
CONIVAPTAN;
MOZAVAPTAN;
N TERT BUTYL 4 [5' ETHOXY 4 (2 MORPHOLINOETHOXY) 2' OXOSPIRO[CYCLOHEXANE 1,3' INDOLE] 1' SULFONYL] 3 METHOXYBENZAMIDE;
RELCOVAPTAN;
UNCLASSIFIED DRUG;
VASOPRESSIN RECEPTOR ANTAGONIST;
ARGIPRESSIN;
BENZAZEPINE DERIVATIVE;
DRUG DERIVATIVE;
VASOPRESSIN RECEPTOR;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG STRUCTURE;
HUMAN;
HYPONATREMIA;
NONHUMAN;
WATER RETENTION;
ANIMAL;
ARTICLE;
CONGESTIVE HEART FAILURE;
DIURESIS;
DRUG ANTAGONISM;
DRUG EFFECT;
EDEMA;
LIVER CIRRHOSIS;
PATHOPHYSIOLOGY;
RAT;
SCHWARTZ BARTTER SYNDROME;
ANIMALS;
ARGININE VASOPRESSIN;
BENZAZEPINES;
DIURESIS;
EDEMA;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPONATREMIA;
INAPPROPRIATE ADH SYNDROME;
LIVER CIRRHOSIS;
RATS;
RECEPTORS, VASOPRESSIN;
|
EID: 0031992316
PISSN: 09182918
EISSN: None
Source Type: Journal
DOI: 10.2169/internalmedicine.37.217 Document Type: Conference Paper |
Times cited : (5)
|
References (0)
|